FDA Wants To Review Drug Companies' Posts And Tweets
The U.S. Food and Drug Administration has issued draft guidance addressing some of the unique challenges of drug promotion in the age of social media. Specifically, the draft guidance sheds light...To view the full article, register now.
Already a subscriber? Click here to view full article